Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Lefebvre

Showing results (321-330 of 340) with videos related to

Pageof 34
Sort By:
Journal of Extracellular Vesicles|May 10, 2019
Proteomic characterisation of leech microglia extracellular vesicles (EVs): comparison between differential ultracentrifugation and Optiprep™ density gradient isolationT Arab, A Raffo-Romero, C Van Camp, et al.
Mucosal Immunology|December 17, 2008
Gene-centric association mapping of chromosome 3p implicates MST1 in IBD pathogenesisP Goyette, C Lefebvre, A Ng, et al.
Breast (Edinburgh, Scotland)|May 24, 2016
Evaluation of sentinel lymph node biopsy after previous breast surgery for breast cancer: GATA studyC Renaudeau, C Lefebvre-Lacoeuille, L Campion, et al.
Leukemia|June 23, 2006
Nucleophosmin status may influence the therapeutic decision in de novo acute myeloid leukemia with normal karyotypeV Bardet, L D Costa, C Elie, et al.
Physical Review Letters|October 2, 2009
Molecular dissociative ionization and wave-packet dynamics studied using two-color XUV and IR pump-probe spectroscopyF Kelkensberg, C Lefebvre, W Siu, et al.
Leukemia|April 17, 2022
The complex karyotype in hematological malignancies: a comprehensive overview by the Francophone Group of Hematological Cytogenetics (GFCH)F Nguyen-Khac, A Bidet, A Daudignon, et al.
Breast Cancer Research and Treatment|October 22, 2018
Sentinel lymph node biopsy without axillary lymphadenectomy after neoadjuvant chemotherapy is accurate and safe for selected patients: the GANEA 2 studyJean-Marc Classe, Cecile Loaec, P Gimbergues, et al.
Genes and Immunity|July 25, 2008
MAST3: a novel IBD risk factor that modulates TLR4 signalingC Labbé, P Goyette, C Lefebvre, et al.
Genome Research|June 15, 2007
The landscape of histone modifications across 1% of the human genome in five human cell linesChristoph M Koch, Robert M Andrews, Paul Flicek, et al.
Leukemia|May 2, 2008
The most frequent t(14;19)(q32;q13)-positive B-cell malignancy corresponds to an aggressive subgroup of atypical chronic lymphocytic leukemiaE Chapiro, I Radford-Weiss, C Bastard, et al.
Pageof 34

Showing results (321-330 of 340) with videos related to

Sort By:
Pageof 34
Journal of Extracellular Vesicles|May 10, 2019
Proteomic characterisation of leech microglia extracellular vesicles (EVs): comparison between differential ultracentrifugation and Optiprep™ density gradient isolationT Arab, A Raffo-Romero, C Van Camp, et al.
Mucosal Immunology|December 17, 2008
Gene-centric association mapping of chromosome 3p implicates MST1 in IBD pathogenesisP Goyette, C Lefebvre, A Ng, et al.
Breast (Edinburgh, Scotland)|May 24, 2016
Evaluation of sentinel lymph node biopsy after previous breast surgery for breast cancer: GATA studyC Renaudeau, C Lefebvre-Lacoeuille, L Campion, et al.
Leukemia|June 23, 2006
Nucleophosmin status may influence the therapeutic decision in de novo acute myeloid leukemia with normal karyotypeV Bardet, L D Costa, C Elie, et al.
Physical Review Letters|October 2, 2009
Molecular dissociative ionization and wave-packet dynamics studied using two-color XUV and IR pump-probe spectroscopyF Kelkensberg, C Lefebvre, W Siu, et al.
Leukemia|April 17, 2022
The complex karyotype in hematological malignancies: a comprehensive overview by the Francophone Group of Hematological Cytogenetics (GFCH)F Nguyen-Khac, A Bidet, A Daudignon, et al.
Breast Cancer Research and Treatment|October 22, 2018
Sentinel lymph node biopsy without axillary lymphadenectomy after neoadjuvant chemotherapy is accurate and safe for selected patients: the GANEA 2 studyJean-Marc Classe, Cecile Loaec, P Gimbergues, et al.
Genes and Immunity|July 25, 2008
MAST3: a novel IBD risk factor that modulates TLR4 signalingC Labbé, P Goyette, C Lefebvre, et al.
Genome Research|June 15, 2007
The landscape of histone modifications across 1% of the human genome in five human cell linesChristoph M Koch, Robert M Andrews, Paul Flicek, et al.
Leukemia|May 2, 2008
The most frequent t(14;19)(q32;q13)-positive B-cell malignancy corresponds to an aggressive subgroup of atypical chronic lymphocytic leukemiaE Chapiro, I Radford-Weiss, C Bastard, et al.
Pageof 34